Billion Doses of Novavax COVID-19 Vaccine to be Produced in Czech Republic, an Industrial Info Market Brief
Billion Doses of Novavax COVID-19 Vaccine to be Produced in Czech Republic, an Industrial Info Market Brief
Attachment: novavaxcz
According to idnes.cz news portal, Novavax plans to produce over a billion doses of new COVID-19 vaccine at a recently bought plant in Czech Republic. The plant is undergoing an expansion. Currently, clinical trials are ongoing.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021